Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viewpoint
  • Published:

Microalbuminuria: do we need a new threshold?

Journal of Human Hypertension volume 23, pages 146–149 (2009)Cite this article

Abstract

Microalbuminuria (30–300 mg of albumin/24 h) is a well-known independent risk factor for kidney and cardiovascular disease and of mortality in diabetic, hypertensive and in the general population. However, recent studies indicate that increased risk is observed at levels of albuminuria much lower than those currently employed to define microalbuminuria. Such low levels were shown to predict heart disease and death, independent of age, sex, renal function, diabetes, hypertension and lipids, in subjects with cardiovascular disease, hypertension and in the general population; as well as to predict progression to hypertension. Correction of obesity and metabolic derangements lowered levels of albuminuria below 30 mg/24 h to levels not associated with increased risk (5–7 mg/24 h). Despite the lack of outcome studies, there is substantial evidence to indicate that the threshold for defining microalbuminuria (that is, albuminuria associated with increased risk) should be lowered by nearly three to four-fold from the currently defined threshold. It would be advisable that clinical scores and future guidelines would consider including microalbuminuria at the lower rates as an independent risk factor, and as an indication for implementing early intervention. Unfortunately, and despite the abundance of evidence, albuminuria measurements are still underutilized in clinical practice.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E et al. Microalbuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985–1986; 9: 85–95.

    Article  Google Scholar 

  2. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H . Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430–1432.

    Article  CAS  Google Scholar 

  3. Mogensen CE . Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes mellitus. N Engl J Med 1984; 310: 356–360.

    Article  CAS  Google Scholar 

  4. Jerums G, MacIsaac RJ . Treatment of microalbuminuria in patients with type 2 diabetes mellitus. Treat Endocrinol 2002; 1: 163–173.

    Article  CAS  Google Scholar 

  5. Kalladiedde J, Viberti G . Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17: 986–993.

    Article  Google Scholar 

  6. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 200; 286: 421–426.

    Article  Google Scholar 

  7. Jager A, Kostense PJ, Ruhé HG, Heine RJ, Nijpels G, Dekker JM et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617–624.

    Article  CAS  Google Scholar 

  8. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK . Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary artery disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893–2898.

    Article  CAS  Google Scholar 

  9. Yudkin JS, Forrest RD, Jorgensen OD, Mogensen CE . Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988; ii: 530–533.

    Article  Google Scholar 

  10. Bigazzi R, Bianchi S, Baldari D, Campese VM . Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16: 1325–1333.

    Article  CAS  Google Scholar 

  11. Redon J, Liao Y, Lozano JV, Miralles A, Pascual JM, Cooper RS . Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 1994; 12: 947–953.

    Article  CAS  Google Scholar 

  12. Ljungman S, Wikstrand J, Hartford M, Berglund G . Urinary albumin excretion—a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9: 770–778.

    Article  CAS  Google Scholar 

  13. Gorgels WJ, van der Graaf Y, Hjemdahl P, Kortlandt W, Collette HJ, Erkelens DW et al. Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case–control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands. Am J Epidemiol 1995; 142: 1157–1164.

    Article  CAS  Google Scholar 

  14. de Zeeuw D, Parving HH, Henning RH . Microalbuminuria as an early marker for cardiovascular disease. J Am Soc Nephrol 2006; 17: 2100–2105.

    Article  CAS  Google Scholar 

  15. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the life study. Ann Intern Med 2003; 139: 901–906.

    Article  Google Scholar 

  16. Dell’Omo G, Penno G, Giorgi D, Di Bello V, Mariani M, Pedrinelli R . Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis 2002; 40: 1–8.

    Article  Google Scholar 

  17. Cubeddu LX, Hoffmann IS, Aponte LM, Nunez-Bogesits R, Medina-Suniaga H, Roa M et al. Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. Am J Hypertens 2003; 16: 343–349.

    Article  CAS  Google Scholar 

  18. Hoffmann IS, Jimenez E, Cubeddu LX . Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Hum Hypertens 2001; 15: 407–412.

    Article  CAS  Google Scholar 

  19. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Clausen P, Appleyard M, Jensen G . Microalbuminuria and its relation to cardiovascular disease and risk factors: a population-based study of 1254 hypertensive individuals. J Hum Hypertens 1997; 11: 727–732.

    Article  CAS  Google Scholar 

  20. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H . Microalbuminuria and all-cause mortality in 2089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. Am J Kidney Dis 2003; 42: 466–473.

    Article  Google Scholar 

  21. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS . Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992–1997.

    Article  CAS  Google Scholar 

  22. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D’Agostino RB et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005; 111: 1370–1376.

    Article  CAS  Google Scholar 

  23. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32–35.

    Article  CAS  Google Scholar 

  24. Klausen KP, Scharling H, Jensen G, Jensen JS . New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 2005; 46: 33–37.

    Article  CAS  Google Scholar 

  25. Klausen KP, Scharling H, Jensen JS . Very low level of microalbuminuria is associated with increased risk of death in subjects with cardiovascular or cerebrovascular diseases. J Intern Med 2006; 260: 231–237.

    Article  CAS  Google Scholar 

  26. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969–975.

    Article  Google Scholar 

  27. Cubeddu LX, Alfieri AB, Hoffmann IS . Lowering the threshold for defining microalbuminuria: effects of a lifestyle–metformin intervention in obese ‘normoalbuminuric’ non-diabetic subjects. Am J Hypertens 2008; 21: 105–110.

    Article  CAS  Google Scholar 

  28. Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V et al. Bergamo nephrologic diabetes complications trial (BENEDICT) investigators. Preventing microalbuminuria in type 2 diabetes. N Engl J Med 2004; 351: 1941–1951.

    Article  CAS  Google Scholar 

  29. Schjoedt KJ, Rossing K, Juhl TR, Boomsma F, Rossing P, Tarnow L et al. Beneficial impact of spironolactone in diabetic nephropathy. Kidney Int 2005; 68: 2829–2836.

    Article  CAS  Google Scholar 

  30. van Paassen P, de Zeeuw D, Navis G, de Jong PE . Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function. Nephrol Dial Transplant 2000; 15: 637–643.

    Article  CAS  Google Scholar 

  31. Maghliano DJ, Polkinghorne KR, Barr EL, Su Q, Chadban SJ, Zimmet PZ et al. HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol 2007; 18: 3171–3176.

    Article  Google Scholar 

  32. McQueen MJ, Gerstein HC, Pogue J, Mann JF, Yusuf S . Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am J Kidney Dis 2006; 48: 889–896.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL, USA

    C R Zamora

  2. Cardiovascular and Metabolic Research Unit, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, USA

    L X Cubeddu

Authors
  1. C R Zamora
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L X Cubeddu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L X Cubeddu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zamora, C., Cubeddu, L. Microalbuminuria: do we need a new threshold?. J Hum Hypertens 23, 146–149 (2009). https://doi.org/10.1038/jhh.2008.105

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2008.105

Keywords

This article is cited by

Search

Advanced search

Quick links